Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function
- 13 May 1999
- journal article
- Published by Elsevier in Neuroscience
- Vol. 91 (2) , 607-620
- https://doi.org/10.1016/s0306-4522(98)00675-7
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brainEuropean Neuropsychopharmacology, 1996
- Cannabis and the BrainAustralian & New Zealand Journal of Psychiatry, 1996
- Roles of dopamine D1 receptors inΔ9-tetrahydrocannabinol-induced expression of Fos protein in the rat brainBrain Research, 1996
- Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysisLife Sciences, 1996
- Novel dopamine receptors half a decade laterTrends in Pharmacological Sciences, 1995
- Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonistLife Sciences, 1995
- Effects of the σ receptor ligand SR 31742A on neurotensin biosynthesis in rat basal gangliaSynapse, 1995
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Stimulus-Transcription Coupling in the Nervous System: Involvement of the Inducible Proto-Oncogenes fos and junAnnual Review of Neuroscience, 1991